Pharmaron Beijing Co Ltd (PHBBF)
1.93
0.00 (0.00%)
USD |
OTCM |
May 14, 08:08
Pharmaron Beijing Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 25, 2024 | 2.955B |
| June 24, 2024 | 2.955B |
| June 21, 2024 | 2.955B |
| June 20, 2024 | 2.955B |
| June 18, 2024 | 2.955B |
| June 17, 2024 | 2.955B |
| June 14, 2024 | 2.955B |
| June 13, 2024 | 2.955B |
| June 12, 2024 | 2.955B |
| June 11, 2024 | 2.955B |
| June 10, 2024 | 2.955B |
| June 07, 2024 | 2.955B |
| June 06, 2024 | 2.955B |
| June 05, 2024 | 2.955B |
| June 04, 2024 | 2.955B |
| June 03, 2024 | 2.955B |
| May 31, 2024 | 2.955B |
| May 30, 2024 | 2.955B |
| May 29, 2024 | 2.955B |
| May 28, 2024 | 2.955B |
| May 24, 2024 | 2.955B |
| May 23, 2024 | 2.955B |
| May 22, 2024 | 2.955B |
| May 21, 2024 | 2.955B |
| May 20, 2024 | 2.955B |
| Date | Value |
|---|---|
| May 17, 2024 | 2.955B |
| May 16, 2024 | 2.955B |
| May 15, 2024 | 2.955B |
| May 14, 2024 | 2.955B |
| May 13, 2024 | 3.369B |
| May 10, 2024 | 3.369B |
| May 09, 2024 | 3.369B |
| May 08, 2024 | 3.369B |
| May 07, 2024 | 3.369B |
| May 06, 2024 | 3.369B |
| May 03, 2024 | 3.369B |
| May 02, 2024 | 3.369B |
| May 01, 2024 | 3.369B |
| April 30, 2024 | 3.369B |
| April 29, 2024 | 3.369B |
| April 26, 2024 | 3.369B |
| April 25, 2024 | 3.369B |
| April 24, 2024 | 3.369B |
| April 23, 2024 | 3.369B |
| April 22, 2024 | 3.369B |
| April 19, 2024 | 3.369B |
| April 18, 2024 | 3.369B |
| April 17, 2024 | 3.369B |
| April 16, 2024 | 3.369B |
| April 15, 2024 | 3.369B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
2.955B
Minimum
May 14 2024
3.369B
Maximum
Sep 27 2023
3.305B
Average
3.369B
Median
Sep 27 2023
Enterprise Value Benchmarks
| Global Pharmatech Inc | -- |
| Sino Biopharmaceutical Ltd | 7.123B |
| HUTCHMED (China) Ltd | 2.250B |
| Regencell Bioscience Holdings Ltd | 48.41M |
| Prenetics Global Ltd | 12.17M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 50.88M |
| Revenue (Quarterly) | 397.98M |
| Total Expenses (Quarterly) | 335.19M |
| EPS Diluted (Quarterly) | 0.0431 |